We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS: REIMPORTATION HIKES COUNTERFEIT RISK
DRUGMAKERS: REIMPORTATION HIKES COUNTERFEIT RISK
April 9, 2004
Representatives from brand and generic drugmakers joined forces last week to launch a sharp counterattack against reimportation, charging that allowing the practice could endanger Americans’ safety by greatly increasing the potential for counterfeiting prescription drugs and threatening innovation fostered by free-market competition.